Get 20% lifetime commission for referring investors to digrin.com
here.
Verrica Pharmaceuticals Inc. ( VRCA) - Key Metrics
VRCA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.28 | -$0.62 | -$0.44 | -$0.44 |
| 2026Q1 | $0.24 | -$0.45 | -$0.43 | -$0.43 |
| 2025Q4 | $0.48 | -$0.76 | -$0.43 | -$0.43 |
| 2025Q3 | $1.51 | -$0.03 | $1.02 | $1.02 |
| 2025Q2 | $1.34 | $0.02 | -$1.06 | -$1.06 |
VRCA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -2.47 |
| 2026Q1 | 0% | -2.94 |
| 2025Q4 | 0% | -3.25 |
| 2025Q3 | 0% | -35.92 |
| 2025Q2 | 0% | 61.63 |
VRCA
Price: $4.68
52 week price:
Earnings Per Share: -1.69 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 337100
Market Capitalization: 87.4 million